StonvexLoading…
StonvexStonvexStonvexCore line items from XWEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $29.21M | $33.90M | $30.11M | $22.71M |
Operating Income | $-15.67M | $-16.71M | $-28.21M | $-23.10M |
Net Income | $-16.99M | $-16.85M | $-27.74M | $-22.77M |
EPS (Diluted) | $-5.08 | $-3.66 | $-6.64 | $-5.46 |
Total Assets | $11.22M | $25.35M | $38.99M | $42.94M |
Total Liabilities | $23.80M | $17.61M | $18.02M | $17.28M |
Cash & Equivalents | $2.62M | $4.55M | $8.44M | $4.83M |
Free Cash Flow OCF − CapEx | $-11.68M | $-12.79M | $-17.98M | $-14.51M |
Shares Outstanding | 6.07M | 5.26M | 4.18M | 4.17M |